-
-
-
-
-
-
-
William Blair Downgrades Zealand Pharma A/S (ZEAL:DC) (ZEAL) to Market Perform, Removed from Analyst Conviction List
-
-
-
-
-
-
-
BNP Paribas Exane Starts Zealand Pharma A/S (ZEAL:DC) (ZEAL) at Outperform
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Zealand Pharma A/S (ZEAL:DC) (ZEAL)
-
-
-
-
-
-
-
Zealand Pharma (ZEAL) launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion
-
422,418 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

